Gastrointestinal Products Market Size Report Predicts Healthy Growth with Demand & Forecasts by 2034

Gastrointestinal Products-Market Insights, Size Revenue, Outlook, Overview, and Analysis. The gastrointestinal products market was estimated to be worth USD 14.42 billion in 2024 and is predicted to expand to USD 25.85 billion by 2034, with a CAGR of 6.0% from 2025 to 2034.

𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐜𝐨𝐩𝐞:
This comprehensive study provides an accurate overview of the worldwide gastrointestinal products market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by devices, disease, end user, and region in the study, which offers a comprehensive picture of the state of the market.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/gastrointestinal-products-market/request-for-sample

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧:
Gastrointestinal products are medical or OTC items created to aid or address issues associated with the digestive system. They include medications, supplements, and instruments designed to treat conditions such as acid reflux, irritable bowel syndrome (IBS), constipation, diarrhea, and ulcers. Gastrointestinal products help reduce symptoms, enhance digestion, and promote overall gut health for those with digestive issues.

𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐓𝐫𝐞𝐧𝐝𝐬:
• The increasing occurrence of gastrointestinal conditions, such as acid reflux, ulcers, and irritable bowel syndrome, is substantially fueling market expansion. As a larger number of people face these issues, the need for efficient treatments and preventive measures has risen.
• Heightened awareness of gut health has prompted consumers to look for ways to avert digestive problems before they escalate. This movement towards preventive care is driven by greater access to information and the availability of over-the-counter gastrointestinal products that enhance digestive health.

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:
Intense competition in the market requires top companies to rely on advanced technology, high-quality products, and a strong brand image to boost sales. Here are the top companies in the gastrointestinal products market:
• Abbott Laboratories
• Johnson & Johnson
• Pfizer Inc.
• Bayer AG
• Astellas Pharma Inc.
• Takeda Pharmaceutical Company
• Novartis International AG
• GSK (GlaxoSmithKline)
• Mylan N.V.
• Santen Pharmaceutical Co., Ltd.
• Dr. Reddy's Laboratories Ltd.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/gastrointestinal-products-market/request-for-discount-pricing

𝐂𝐨𝐮𝐧𝐭𝐫𝐲-𝐖𝐢𝐬𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
According to regional analysis, in 2024, North America led the global market because of the elevated incidence of gastrointestinal issues, including gastroesophageal reflux disease (GERD) and inflammatory bowel disease (IBD).
Asia Pacific is also anticipated to be the fastest-growing region during the projection period due to escalating healthcare costs, heightened awareness of digestive health, and a surging population experiencing lifestyle-related issues like obesity and gastrointestinal conditions/

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:
By Devices Outlook (Revenue, USD Billion, 2020-2034)
• Endoscopy
o Colonoscopy
o Sigmoidoscopes
o Capsule endoscopy systems
o Other endoscopy devices/accessories
• Ablation system
o Radiofrequency Ablation system
o Microwave Ablation system
o Cryoablation system
o Other ablation system
• Motility testing
o Esophageal Manometry
o 4-hour pH impedance testing
o Anorectal Manometry
o Other Motility testing
• Biopsy Devices
o Needle Biopsy Devices
o Endoscopic mucosal resection (EMR) devices
o Endoscopic submucosal dissection (ESD) devices
o Other Biopsy accessory products
• Stenting Devices
• pH monitoring devices
• Other gastroenterology devices

By Disease Outlook (Revenue, USD Billion, 2020-2034)
• Inflammatory Bowel Disease (IBD)
• Gastroesophageal reflux disease (GERD)
• Irritable bowel syndrome (IBS)
• Gastrointestinal cancer
• Other diseases

By End User Outlook (Revenue, USD Billion, 2020-2034)
• Hospitals
• Ambulatory surgical centres and Independent diagnostic centres
• Clinics
• Other end users

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/gastrointestinal-products-market/inquire-before-buying

𝐆𝐚𝐬𝐭𝐫𝐨𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• In terms of disease, in 2024, gastroesophageal reflux disease (GERD) has emerged as the leading segment in the global gastrointestinal products market due to its widespread prevalence and growing public awareness.
• The ambulatory surgical centers (ASCs) segment is witnessing rapid growth in the gastrointestinal products market, driven by an increasing preference for outpatient procedures.
• In 2024, North America led the gastrointestinal products market, largely due to the prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and inflammatory bowel disease (IBD).
• Asia Pacific is projected to experience the fastest growth during the forecast period, driven by increasing healthcare spending, heightened awareness of gastrointestinal health, and a rising population grappling with lifestyle-related issues.
• A few global key market players include Abbott Laboratories; Johnson & Johnson; Pfizer Inc.; Bayer AG; Astellas Pharma Inc.; Takeda Pharmaceutical Company; Novartis International AG; GSK (GlaxoSmithKline); Mylan N.V.; Santen Pharmaceutical Co., Ltd.; Dr. Reddy's Laboratories Ltd.

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭:
Laparoscopic Retrieval Bag Market
https://www.polarismarketresearch.com/industry-analysis/laparoscopic-retrieval-bag-market

Lower Extremity Implants Market
https://www.polarismarketresearch.com/industry-analysis/lower-extremity-implants-market

Patient Support Technology Market
https://www.polarismarketresearch.com/industry-analysis/patient-support-technology-market

Medical Device Engineering Market
https://www.polarismarketresearch.com/industry-analysis/medical-device-engineering-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.